A novel approach to characterise pathogen candidate genetic polymorphisms involved in clinical outcome

Infection, Genetics and Evolution

Volumn 6, Issue 1, 2006, Pages 38-45

  Szmaragd, Camille ^a   Nichols, Richard A ^b   Balloux, François ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Clinical outcome; Gene mapping; Generalised linear modelling; HBV; Hepatitis B; Host pathogen interaction; Phylogenetics

Indexed keywords

ACUTE HEPATITIS; ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CHRONIC HEPATITIS; ENVIRONMENTAL FACTOR; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIAL GENETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; ONSET AGE; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; STATISTICAL MODEL; UNINDEXED SEQUENCE; VIRUS GENOME; VIRUS VIRULENCE;

HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNITY, NATURAL; MODELS, GENETIC; MODELS, STATISTICAL; POLYMORPHISM, GENETIC;

HEPATITIS B VIRUS;

EID: 31044449222     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2005.01.001     Document Type: Article

References (40)

1. P. Arauz-Ruiz H. Norder B.H. Robertson L.O. Magnius Genotype H: A new Ameridian genotype of hepatitis B virus revealed in Central America J. Gen. Virol. 83 2002 2059-2073
2. T.F. Baumert S.A. Rogers K. Hasegawa T.J. Liang Two core promotor mutations identified in a hepatitis B virus strains associated with fulminant hepatitis result in enhanced viral replication J. Clin. Invest. 98 10 1996 2268-2276
3. W.N. Chen C.J. Oon hepatitis B virus surface antigen (HBsAg) mutants in Singapore adults and vaccinated children with high anti-hepatitis B virus antibody levels but negative for HBsAg J. Clin. Microbiol. 38 7 2000 2793-2794
4. Chevenet, F., Bàñul A.L., Barnabé, C., 2000. TreeDyn: Un éditeur interactif d'arbres phylogénétiques. Actes des Premières Journées Ouvertes Biologie, Informatique et Mathématiques, ENSAM/Montpellier. pp. 87-90.
5. J. Felsenstein Phylogenies from molecular sequences: Inference and reliability Annu. Rev. Genet. 22 1 1988 521-565
6. S. Günther Naturally occurring mutations of hepatitis B virus and outcome of chronic infection: Is there an association? Eur. J. Clin. Invest. 30 2000 751-753
7. J. Hardy A. Singleton K. Gwinn-Hardy Ethnic differences and disease phenotypes Science 300 5620 2003 739-740
8. C. Kapp WHO warns of microbial threat Lancet 353 9171 1999 2222
9. K. Kidd-Ljunggren Y. Miyakawa A.H. Kidd Genetic variability in hepatitis B viruses J. Gen. Virol. 83 2002 1267-1280
10. B. Kolaczkowski J.W. Thornton Performance of maximum parsimony and likelihood phylogenetics when evolution is heterogeneous Nature 431 7011 2004 980-984
11. C.-L. Lai J. Dienstag E. Schiff N.W.Y. Leung M. Atkins C. Hunt N. Brown M. Woessner R. Boehme L. Condreay Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B Clin. Infect. Dis. 36 2003 687-696
12. C.-J. Liu J.-H. Kao W.-Y. Shau P.-J. Chen M.-Y. Lai D.-S. Chen Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: Correlation with viral serotypes and clinical stages of liver disease J. Med. Virol. 68 2002 50-59
13. S. Locarnini Hepatitis B viral resistance: Mechanisms and diagnosis J. Hepatol. 39 Suppl. 1 2003 S124-S132
14. C. Mayerat A. Mantegani P.C. Frei Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? J. Viral. Hepat. 6 1999 299-304
15. M. Mizokami E. Orito K. Ohba K. Ikeo J.Y. Lau T. Gojobori Constrained evolution with respect to gene overlap of hepatitis B virus J. Mol. Evol. 44 Suppl. 1 1997 S83-S90
16. M. Nei S. Kumar Molecular Evolution and Phylogenetics 2000 Oxford University Press Inc. New York
17. Y.-H. Ni M.-H. Chang H.-Y. Hsu D.-J. Tsuei Different hepatitis B virus core gene mutations in children with chronic infection and hepatocellular carcinoma GUT 52 2003 122-125
18. C.J. Oon W.N. Chen N. Lim S. Koh G.K. Lim A.L. Leong G.D. Tan Hepatitis B virus variants with lamivudine-related mutations in the DNA polymerase ant the 'a' epitope of the surface antigen are sensitive to ganciclovir Antivir. Res. 41 1999 113-118
19. N. Previsani D. Lavanchy Hepatitis B 2002 World Health Organization Department of Communicable Diseases Surveillance and Response
20. D.E. Reich E.S. Lander On the allelic spectrum of human disease Trends Genet. 17 9 2001 502-510
21. W.S. Robinson Hepatitis B Viruses. General Features (human) Encyclopaedia of Virology 1994 Academic Press Ltd. London
22. N.A. Rosenberg J.K. Pritchard J.L. Weber H.M. Cann K.K. Kidd L.A. Zhivotovsky M.W. Feldman Genetic structure of human populations Science 298 5602 2002 2381-2385
23. M. Salemi A.-M. Vandamme The Phylogenetic Handbook. A Practical Approach to DNA and Protein Phylogeny 2003 Cambridge University Press
24. M.E. Siddall M.F. Whiting Long-branch abstractions Cladistics 15 1999 9-24
25. P.S. Soltis D.E. Soltis Applying the bootstrap in phylogeny reconstruction Stat. Sci. 18 2 2003 256-267
26. L. Stuyver S. De Gendt C. Van Geyt F. Zoulim M. Friedt R.F. Schinazi R. Rossau A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness J. Gen. Virol. 81 2000 67-74
27. L.J. Stuyver S.A. Locarnini A. Lok D.D. Richman W.F. Carman J.L. Dienstag R.F. Schinazi Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region Hepatology 33 3 2001 751-757
28. Swofford, D.L., 2002. PAUP* Phylogenetic Analysis Using Parsimony (and other methods), v.4.0b10. Sinauer Associates, Sunderland, Massachusetts.
29. P.-C. Tai D. Banik G.-I. Lin S. Pai K. Pai M.-H. Lin G. Yuoh S. Che S.H. Hsu T.-C. Chen T.-T. Kuo C.-S. Lee C.-S. Yang C. Shih Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen J. Virol. 71 6 1997 4852-4856
30. J.D. Thompson T.J. Gibson F. Plewniak F. Jeanmougin D.C. Higgins The ClustalX window interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools Nucleic Acids Res. 24 1997 4876-4882
31. P. Tiollais C. Pourcel A. Dejean The hepatitis B virus Nature 317 1985 489-495
32. F. Torre N.V. Naoumov Clinical implications of mutations in the hepatitis B virus genome Eur. J. Clin. Invest. 28 8 1998 604-614
33. J. Torresi The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus J. Clin. Virol. 25 2 2002 97-106
34. J. Torresi L. Earnest-Silveira G. Deliyannis K. Edgtton H. Zhuang S.A. Locarnini J. Fyfe T. Sozzi D.C. Jackson Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy Virology 293 2002 305-313
35. A. Tsubota H. Kumada K. Takaki K. Chayama M. Kobayashi Y. Suzuki S. Saitoh Y. Arase N. Murashima K. Ikeda Deletions in the hepatitis B virus core gene may influence the clinical outcome in hepatitis B e antigen-positive asymptomatic healthy carriers J. Med. Virol. 56 4 1998 287-293
36. W.N. Venables B.D. Ripley Generalized linear models Modern Applied Statistics with S 1999 Springer New York pp. 183-210
37. W.N. Venables B.D. Ripley Poisson and multinomial models Modern Applied Statistics with S 1999 Springer New York pp. 199-205
38. F.A. Waldvogel Infectious diseases in the 21st century: Old challenges and new opportunities Int. J. Infect. Dis. 8 1 2004 5-12
39. F.-S. Wang Current status and prospects studies on human genetic alleles associated with hepatitis B virus infection World J. Gastroenterol. 9 4 2003 641-644
40. K.M. Weinberger T. Bauer S. Bohm W. Jilg High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum J. Gen. Virol. 81 5 2000 1165-1174